About Matrix-Bio    Leadership

Matrix-Bio’s leadership team has extensive experience in developing metabolite profile diagnostic tests and in starting and building successful healthcare companies. We are also collaborating with thought leaders in the field of hepatology to clinically validate our test for hepatocellular cancer (HCC).

Daniel Raftery, PhD, MBA
Founder and Chief Scientific Officer

bio_danDaniel Raftery is the chief scientific officer and founder of Matrix-Bio, Inc. A nationally recognized expert in the field of metabolomics, he invented the biomarker analysis methodology that forms the core of the company’s technology. He has more than 20 years of experience in nuclear magnetic resonance and mass spectrometry analysis, the gold standards for metabolite biomarker analysis.

Raftery is a Medical Education and Research Endowed Professor in the Department of Anesthesia and Pain Medicine and Director of the Northwest Metabolomics Research Center at the University of Washington in Seattle. He is also a member of one of the world’s leading cancer research centers, the Fred Hutchinson Cancer Research Center in Seattle. The National Institutes of Health and U.S. Department of Defense support Raftery’s work. Prior to joining the University of Washington, Raftery was a professor of Analytical and Physical Chemistry at Purdue University in West Lafayette, IN, where Matrix-Bio was founded in 2007.

A graduate of Harvard College, Raftery earned his PhD from the University of California, Berkeley. He earned his MBA from the University of Chicago. He completed a National Science Foundation postdoctoral fellowship at the University of Pennsylvania. He has received numerous national and international awards and is widely published.

Eric G. Beier, MD, MBA
Chief Executive Officer


Dr. Eric Beier is the CEO of Matrix-Bio, Inc., and a member of the Matrix-Bio Board of Directors representing the Main Street Venture Fund. He is also the president of the Fort Wayne Chapter of VisionTech Angels. Prior positions include chief medical officer of MediGain, a global physician revenue cycle management company. He was the founder and president of MedOptima, a physician revenue cycle management, practice management, and consulting company purchased by MediGain. He also has started up several physician practices and an emergency medicine billing company. Dr. Beier was the product line manager for Cardiovascular Diagnostics at Boehringer Mannheim Corporation (now part of Roche Diagnostics) and practiced as an emergency physician in Indiana.

Dr. Beier graduated summa cum laude from Hanover College with a Bachelor’s of Arts in Chemistry. He earned his medical degree from the Indiana University School of Medicine and an MBA from the University of Michigan.


If you have questions about Matrix-Bio’s early liver cancer detection test or about our investing and partnership opportunities, please contact:

Eric Beier, MD, MBA